Drug Shortage Report for CESAMET
| Report ID | 3308 |
| Drug Identification Number | 02312263 |
| Brand name | CESAMET |
| Common or Proper name | CESAMET |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | NABILONE |
| Strength(s) | 0.25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 50 |
| ATC code | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2018-02-15 |
| Actual start date | |
| Estimated end date | 2018-05-15 |
| Actual end date | 2018-02-15 |
| Shortage status | Resolved |
| Updated date | 2018-02-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2018-02-16 | French | Compare |
| v7 | 2018-02-16 | English | Compare |
| v6 | 2018-02-16 | English | Compare |
| v5 | 2018-01-23 | French | Compare |
| v4 | 2018-01-23 | English | Compare |
| v3 | 2017-06-16 | English | Compare |
| v2 | 2017-03-17 | French | Compare |
| v1 | 2017-03-17 | English | Compare |
Showing 1 to 8 of 8